You can view the current or previous issues of Diabetes Health online, in their entirety, anytime you want.
Click Here To View
Latest Insulin Articles
Popular Insulin Articles
Highly Recommended Insulin Articles
Send a link to this page to your friends and colleagues.
On April 3, SmithKline Beecham announced that the FDA has approved Avandia for use as a treatment in combination with sulfonylureas. Previously, Avandia had been approved for treating type 2 diabetes as both monotherapy and in combination with Glucophage.
In patients inadequately controlled on sulfonylureas alone, the safety and efficacy of Avandia was evaluated in combination with sulfonylureas. In three randomized, double-blind, 6-month studies, both fasting plasma glucose (FPG) and HbA1c were significantly improved in patients given Avandia plus sulfonylureas, as compared to those given sulfonylureas alone. The combination therapy produced and maintained impressive reductions in FPG and HbA1c throughout the duration of the trials.
Now Available in Canada
"The Canadian Diabetes Association recommends that Canadians with diabetes discuss any new treatment option with their physician to determine if it is appropriate," said Donna Lillie, director of research and professional education for the Canadian Diabetes Association.
It is estimated that 1.5 million Canadians are currently diagnosed with diabetes, while another 750,000 people are currently undiagnosed. In addition to Canada's approval, Avandia has received marketing approval in 26 countries.
0 comments - May 1, 2000
Diabetes Health is the essential resource for people living with diabetes- both newly diagnosed and experienced as well as the professionals who care for them. We provide balanced expert news and information on living healthfully with diabetes. Each issue includes cutting-edge editorial coverage of new products, research, treatment options, and meaningful lifestyle issues.